Current issues in pediatric stem cell transplantation

Clinics in Laboratory Medicine

Volumn 25, Issue 3, 2005, Pages 519-540

  Savaşan, Süreyya ^a   Abella, Esteban M ^b  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b Arizona Pediatric Hematology Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IMMUNOSUPPRESSIVE AGENT; ISOTRETINOIN; MELPHALAN; NAVELBINE; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASIA; APLASTIC ANEMIA; BLOOD; BONE MARROW; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DONOR; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMORRHAGIC CYSTITIS; HIGH RISK PATIENT; HLA SYSTEM; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY; MEDICAL TECHNOLOGY; MORTALITY; MYELODYSPLASIA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PANCYTOPENIA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STEM CELL TRANSPLANTATION; TOXICITY; UMBILICAL CORD BLOOD; VEIN OCCLUSION; WHOLE BODY RADIATION;

ANEMIA, APLASTIC; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM DISEASES; LEUKEMIA; LYMPHOMA; NERVOUS SYSTEM NEOPLASMS; NEUROBLASTOMA;

EID: 23944514104     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2005.06.009     Document Type: Review

References (105)

1. E. Gluckman, H.A. Broxmeyer, and A.D. Auerbach Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling N Engl J Med 321 17 1989 1174 1178
2. C. Kollman, E. Abella, and R.L. Baitty Assessment of optimal size and composition of the US National Registry of hematopoietic stem cell donors Transplantation 78 1 2004 89 95
3. W.C. Mentzer, S. Heller, and P.R. Pearle Availability of related donors for bone marrow transplantation in sickle cell anemia Am J Pediatr Hematol Oncol 16 1 1994 27 29
4. V. Rocha, G. Sanz, and E. Gluckman Umbilical cord blood transplantation Curr Opin Hematol 11 6 2004 375 385
5. R. Ladenstein, C. Lasset, and O. Hartmann Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation Bone Marrow Transplant 14 1 1994 37 46
6. K.K. Matthay, R.C. Seeger, and C.P. Reynolds Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group J Clin Oncol 12 11 1994 2382 2389
7. Y. Ravindranath, A.M. Yeager, and M.N. Chang Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group N Engl J Med 334 22 1996 1428 1434
8. S. Neudorf, J. Sanders, and N. Kobrinsky Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival Blood 103 10 2004 3655 3661
9. A. Wawer, H.J. Laws, and D. Dilloo Long-time survival after unrelated bone marrow transplantation in children and adolescents and targeted therapy with CD25 blockade to prevent GVHD Klin Padiatr 216 3 2004 169 175
10. Y. Ravindranath Recent advances in pediatric acute lymphoblastic and myeloid leukemia Curr Opin Oncol 15 1 2003 23 35
11. M. Chang, S.C. Raimondi, and Y. Ravindranath Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821 Leukemia 14 7 2000 1201 1207
12. Y. Ravindranath, E. Abella, and J.P. Krischer Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498 Blood 80 9 1992 2210 2214
13. I.M. Hann, D.K. Webb, and B.E. Gibson MRC trials in childhood acute myeloid leukaemia Ann Hematol 83 Suppl 1 2004 S108 S112
14. D. Grimwade, H. Walker, and F. Oliver The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties Blood 92 7 1998 2322 2333
15. S.C. Raimondi, M.N. Chang, and Y. Ravindranath Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821 Blood 94 11 1999 3707 3716
16. W.G. Woods, N. Kobrinsky, and J.D. Buckley Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group Blood 87 12 1996 4979 4989
17. A.K. Burnett, K. Wheatley, and A.H. Goldstone The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial Br J Haematol 118 2 2002 385 400
18. W.G. Woods, S. Neudorf, and S. Gold A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission Blood 97 1 2001 56 62
19. K. Godder, M. Eapen, and J.H. Laver Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis J Clin Oncol 22 18 2004 3798 3804
20. J.E. Sanders, C.D. Buckner, and R.A. Clift Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation Bone Marrow Transplant 3 1 1988 11 19
21. I. Kataoka, M. Kami, and S. Takahashi Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party Bone Marrow Transplant 34 8 2004 711 719
22. A. Gustafsson Jernberg, M. Remberger, and O. Ringden Graft-versus- leukaemia effect in children: chronic GVHD has a significant impact on relapse and survival Bone Marrow Transplant 31 3 2003 175 181
23. M. Watson, G. Buck, and K. Wheatley Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial Eur J Cancer 40 7 2004 971 978
24. A. Redaelli, J.M. Stephens, and S. Brandt Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life Cancer Treat Rev 30 1 2004 103 117
25. R. Storb Aplastic anemia J Intraven Nurs 20 6 1997 317 322
26. R. Brodsky Acquired severe aplastic anemia in children: is there a standard of care? Pediatr Blood Cancer 43 7 2004 711 712
27. D.A. Margolis, and J.T. Casper Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia Semin Hematol 37 1 2000 43 55
28. M.M. de Planque, A. Bacigalupo, and A. Wursch Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT) Br J Haematol 73 1 1989 121 126
29. G.E. Georges, and R. Storb Stem cell transplantation for aplastic anemia Int J Hematol 75 2 2002 141 146
30. H.J. Deeg, W. Leisenring, and R. Storb Long-term outcome after marrow transplantation for severe aplastic anemia Blood 91 10 1998 3637 3645
31. G.M. Brodeur, J. Pritchard, and F. Berthold Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment J Clin Oncol 11 8 1993 1466 1477
32. L.M. Franks, A. Bollen, and R.C. Seeger Neuroblastoma in adults and adolescents: an indolent course with poor survival Cancer 79 10 1997 2028 2035
33. H. Shimada, I.M. Ambros, and L.P. Dehner The International Neuroblastoma Pathology Classification (the Shimada system) Cancer 86 2 1999 364 372
34. R. Ladenstein, I.M. Ambros, and U. Potschger Prognostic significance of DNA di-tetraploidy in neuroblastoma Med Pediatr Oncol 36 1 2001 83 92
35. G.M. Brodeur, J.M. Maris, and D.J. Yamashiro Biology and genetics of human neuroblastomas J Pediatr Hematol Oncol 19 2 1997 93 101
36. K.K. Matthay, C. Perez, and R.C. Seeger Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study J Clin Oncol 16 4 1998 1256 1264
37. H.M. Katzenstein, S.L. Cohn, and R.M. Shore Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma J Clin Oncol 22 19 2004 3909 3915
38. T. Philip, R. Ladenstein, and C. Lasset 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party Eur J Cancer 33 12 1997 2130 2135
39. K.K. Matthay, J.G. Villablanca, and R.C. Seeger Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group N Engl J Med 341 16 1999 1165 1173
40. S.A. Grupp, J.W. Stern, and N. Bunin Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma J Clin Oncol 18 13 2000 2567 2575
41. M. Kletzel, H.M. Katzenstein, and P.R. Haut Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study J Clin Oncol 20 9 2002 2284 2292
42. A. Verdeguer, A. Munoz, and A. Canete Long-term results of high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma patients: a report of the Spanish working party for BMT in children (Getmon) Pediatr Hematol Oncol 21 6 2004 495 504
43. M. Kletzel, E.M. Abella, and E.S. Sandler Thiotepa and cyclophosphamide with stem cell rescue for consolidation therapy for children with high-risk neuroblastoma: a phase I/II study of the Pediatric Blood and Marrow Transplant Consortium J Pediatr Hematol Oncol 20 1 1998 49 54
44. R. Handgretinger, W. Leung, and K. Ihm Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news? Br J Cancer 88 12 2003 1874 1877
45. C.P. Reynolds, K.K. Matthay, and J.G. Villablanca Retinoid therapy of high-risk neuroblastoma Cancer Lett 197 1-2 2003 185 192
46. K.J. Marcus, R. Shamberger, and H. Litman Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants J Pediatr Hematol Oncol 25 12 2003 934 940
47. H. Esperou, J.M. Boiron, and J.M. Cayuela A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society Bone Marrow Transplant 31 10 2003 909 918
48. A. Nordlander, J. Mattsson, and O. Ringden Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia Biol Blood Marrow Transplant 10 3 2004 195 203
49. C.H. Pui, P.S. Gaynon, and J.M. Boyett Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region Lancet 359 9321 2002 1909 1915
50. R. Dopfer, G. Henze, and C. Bender-Gotze Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study Blood 78 10 1991 2780 2784
51. C. Uderzo, M.G. Valsecchi, and A. Bacigalupo Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association J Clin Oncol 13 2 1995 352 358
52. A.J. Barrett, M.M. Horowitz, and B.H. Pollock Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission N Engl J Med 331 19 1994 1253 1258
53. C. Rizzari, M.G. Valsecchi, and M. Arico Outcome of very late relapse in children with acute lymphoblastic leukemia Haematologica 89 4 2004 427 434
54. A. Borgmann, A. von Stackelberg, and R. Hartmann Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis Blood 101 10 2003 3835 3839
55. A. Borgmann, H. Schmid, and R. Hartmann Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Munster Study Group Lancet 346 8979 1995 873 876
56. D.J. Weisdorf, M. Bishop, and B. Dharan Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia Blood 90 8 1997 2962 2968
57. A. Oakhill, D.H. Pamphilon, and M.N. Potter Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission Br J Haematol 94 3 1996 574 578
58. F. Locatelli, M. Zecca, and C. Messina Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors Leukemia 16 11 2002 2228 2237
59. F.A. Al-Kasim, I. Thornley, and M. Rolland Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants Br J Haematol 116 2 2002 483 490
60. A.E. Woolfrey, C. Anasetti, and B. Storer Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children Blood 99 6 2002 2002 2008
61. N. Bunin, M. Carston, and D. Wall Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission Blood 99 9 2002 3151 3157
62. S. Singhal, P.J. Henslee-Downey, and R. Powles Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission Bone Marrow Transplant 31 10 2003 889 895
63. P. Lang, R. Handgretinger, and D. Niethammer Transplantation of highly purified CD34 + progenitor cells from unrelated donors in pediatric leukemia Blood 101 4 2003 1630 1636
64. A.K. Ritchey, B.H. Pollock, and S.J. Lauer Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study J Clin Oncol 17 12 1999 3745 3752
65. K. Wheeler, S. Richards, and C. Bailey Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia Br J Haematol 101 1 1998 94 103
66. A. Borgmann, R. Hartmann, and H. Schmid Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group Bone Marrow Transplant 15 4 1995 515 521
67. C. Messina, M.G. Valsecchi, and M. Arico Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia Pediatrica Bone Marrow Transplant 21 1 1998 9 14
68. M. Mrsic, M.M. Horowitz, and K. Atkinson Second HLA-identical sibling transplants for leukemia recurrence Bone Marrow Transplant 9 4 1992 269 275
69. N. Bunin, R. Aplenc, and N. Kamani Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study Bone Marrow Transplant 32 6 2003 543 548
70. C.H. Jamieson, M.D. Amylon, and R.M. Wong Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience Exp Hematol 31 10 2003 981 986
71. M. Moussalem, H. Esperou Bourdeau, and A. Devergie Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease Bone Marrow Transplant 15 6 1995 943 947
72. N. Goulden, P. Bader, and V. Van Der Velden Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia Br J Haematol 122 1 2003 24 29
73. P. Bader, H. Kreyenberg, and W. Hoelle Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? J Clin Oncol 22 9 2004 1696 1705
74. L. Garderet, M. Labopin, and N.C. Gorin Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow Bone Marrow Transplant 31 1 2003 23 29
75. N. Schmitz, M. Beksac, and D. Hasenclever Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia Blood 100 3 2002 761 767
76. D.A. Jacobsohn, B. Hewlett, and M. Ranalli Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia Bone Marrow Transplant 34 10 2004 901 907
77. C.D. Williams, A.H. Goldstone, and R. Pearce Autologous bone marrow transplantation for pediatric Hodgkin's disease: a case-matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Registry J Clin Oncol 11 11 1993 2243 2249
78. S. Stoneham, S. Ashley, and C.R. Pinkerton Outcome after autologous hemopoietic stem cell transplantation in relapsed or refractory childhood Hodgkin disease J Pediatr Hematol Oncol 26 11 2004 740 745
79. Y.E. Lieskovsky, S.S. Donaldson, and M.A. Torres High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices J Clin Oncol 22 22 2004 4532 4540
80. C.H. Moskowitz, T. Kewalramani, and S.D. Nimer Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease Br J Haematol 124 5 2004 645 652
81. T. Kewalramani, S.D. Nimer, and A.D. Zelenetz Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma Bone Marrow Transplant 32 7 2003 673 679
82. A. Sureda, and N. Schmitz Role of allogeneic stem cell transplantation in relapsed or refractory Hodgkin's disease Ann Oncol 13 Suppl 1 2002 128 132
83. A. Claviez, T. Klingebiel, and J. Beyer Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease Ann Hematol 83 4 2004 237 241
84. G. Akpek, R.F. Ambinder, and S. Piantadosi Long-term results of blood and marrow transplantation for Hodgkin's lymphoma J Clin Oncol 19 23 2001 4314 4321
85. T. Philip, P. Biron, and I. Philip Massive therapy and autologous bone marrow transplantation in pediatric and young adults Burkitt's lymphoma (30 courses on 28 patients: a 5-year experience) Eur J Cancer Clin Oncol 22 8 1986 1015 1027
86. N.L. Kobrinsky, R. Sposto, and N.R. Shah Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912 J Clin Oncol 19 9 2001 2390 2396
87. J.T. Sandlund, L. Bowman, and H.E. Heslop Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL Cytotherapy 4 3 2002 253 258
88. J.M. Vose, M.J. Zhang, and P.A. Rowlings Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry J Clin Oncol 19 2 2001 406 413
89. R. Ladenstein, R. Pearce, and O. Hartmann High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: a report from the European Lymphoma Bone Marrow Transplantation Registry Blood 90 8 1997 2921 2930
90. E. Bureo, J.J. Ortega, and A. Munoz Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children Bone Marrow Transplant 15 3 1995 353 359
91. J.E. Levine, R.E. Harris, and F.R. Loberiza Jr. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma Blood 101 7 2003 2476 2482
92. T. Yoshihara, M. Naya, and K. Tsunamoto A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma Anticancer Res 23 2C 2003 1739 1742
93. A. Shimoni, I. Hardan, and A. Avigdor Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma Br J Haematol 122 3 2003 457 464
94. N. Kapoor, G. Crooks, and D.B. Kohn Hematopoietic stem cell transplantation for primary lymphoid immunodeficiencies Semin Hematol 35 4 1998 346 353
95. A.H. Filipovich, J.V. Stone, and S.C. Tomany Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program Blood 97 6 2001 1598 1603
96. M.E. Horwitz Stem-cell transplantation for inherited immunodeficiency disorders Pediatr Clin North Am 47 6 2000 1371 1387
97. R.H. Buckley Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution Annu Rev Immunol 22 2004 625 655
98. W. Friedrich, and S.M. Muller Allogeneic stem cell transplantation for treatment of immunodeficiency Springer Semin Immunopathol 26 1-2 2004 109 118
99. B. Bielorai, L. Trakhtenbrot, and N. Amariglio Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients Bone Marrow Transplant 34 4 2004 317 320
100. J.L. Roberts, A. Lengi, and S.M. Brown Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation Blood 103 6 2004 2009 2018
101. L. Kane, A.R. Gennery, and B.N. Crooks Neonatal bone marrow transplantation for severe combined immunodeficiency Arch Dis Child Fetal Neonatal Ed 85 2 2001 F110 F113
102. A.P. Knutsen, and D.A. Wall Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience J Clin Immunol 20 6 2000 466 476
103. A.P. Knutsen, M. Steffen, and K. Wassmer Umbilical cord blood transplantation in Wiskott Aldrich syndrome J Pediatr 142 5 2003 519 523
104. K. Rao, P.J. Amrolia, and A. Jones Improved survival after unrelated donor bone marrow transplant in children with primary immunodeficiency using a reduced intensity conditioning regimen Blood 105 2005 879 885
105. M.E. Horwitz, A.J. Barrett, and M.R. Brown Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft N Engl J Med 344 12 2001 881 888